The various stages of epithelial-mesenchymal transition (EMT) generate phenotypically heterogeneous populations of cells. Here, we detail a dual recombinase lineage tracing system using a transgenic mouse model of metastatic breast cancer to trace and characterize breast cancer cells at different EMT stages. We describe analytical steps to label cancer cells at an early partial or a late full EMT state, followed by tracking their behavior in tumor slice cultures. We then characterize their transcriptome by five-cell RNA sequencing. For complete details on the use and execution of this protocol, please refer to Luond et al. (2021)
Epithelial-mesenchymal transition (EMT) equips breast cancer cells for metastasis and treatment resi...
We developed stromal- and epithelial-specific cre-transgenic mice to directly visualize epithelial-m...
Epithelial-mesenchymal transition (EMT) equips breast cancer cells for metastasis and treatment resi...
The various stages of epithelial-mesenchymal transition (EMT) generate phenotypically heterogeneous ...
Epithelial-mesenchymal transition (EMT) is a transient, reversible process of cell de-differentiatio...
Breast cancer is a leading cause of mortality in women worldwide. The lethality associated with the ...
INTRODUCTION: Increasing evidence supports a role of an epithelial to mesenchymal transition (EMT) p...
Epithelial-mesenchymal transition (EMT) is an essential developmental program that becomes reactivat...
Epithelial-mesenchymal transition (EMT) is an essential developmental program that becomes reactivat...
Metastases are responsible for the majority of breast cancer�associated deaths. The contribution o...
<div><h3>Introduction</h3><p>Increasing evidence supports a role of an epithelial to mesenchymal tra...
INTRODUCTION: Increasing evidence supports a role of an epithelial to mesenchymal transition (EMT) p...
Epithelial-mesenchymal transition (EMT) equips breast cancer cells for metastasis and treatment resi...
Epithelial-mesenchymal transition (EMT) equips breast cancer cells for metastasis and treatment resi...
Epithelial-mesenchymal transition (EMT) equips breast cancer cells for metastasis and treatment resi...
Epithelial-mesenchymal transition (EMT) equips breast cancer cells for metastasis and treatment resi...
We developed stromal- and epithelial-specific cre-transgenic mice to directly visualize epithelial-m...
Epithelial-mesenchymal transition (EMT) equips breast cancer cells for metastasis and treatment resi...
The various stages of epithelial-mesenchymal transition (EMT) generate phenotypically heterogeneous ...
Epithelial-mesenchymal transition (EMT) is a transient, reversible process of cell de-differentiatio...
Breast cancer is a leading cause of mortality in women worldwide. The lethality associated with the ...
INTRODUCTION: Increasing evidence supports a role of an epithelial to mesenchymal transition (EMT) p...
Epithelial-mesenchymal transition (EMT) is an essential developmental program that becomes reactivat...
Epithelial-mesenchymal transition (EMT) is an essential developmental program that becomes reactivat...
Metastases are responsible for the majority of breast cancer�associated deaths. The contribution o...
<div><h3>Introduction</h3><p>Increasing evidence supports a role of an epithelial to mesenchymal tra...
INTRODUCTION: Increasing evidence supports a role of an epithelial to mesenchymal transition (EMT) p...
Epithelial-mesenchymal transition (EMT) equips breast cancer cells for metastasis and treatment resi...
Epithelial-mesenchymal transition (EMT) equips breast cancer cells for metastasis and treatment resi...
Epithelial-mesenchymal transition (EMT) equips breast cancer cells for metastasis and treatment resi...
Epithelial-mesenchymal transition (EMT) equips breast cancer cells for metastasis and treatment resi...
We developed stromal- and epithelial-specific cre-transgenic mice to directly visualize epithelial-m...
Epithelial-mesenchymal transition (EMT) equips breast cancer cells for metastasis and treatment resi...